|
Indian Pediatr 2014;51: 303-305 |
|
Furosemide Infusion in Children with Dengue
Fever and Hypoxemia
|
KR Bharath Kumar Reddy, GV Basavaraja and Shivananda
From Department of Pediatric Intensive Care, Indira
Gandhi Institute of Child Health, Bangalore, Karnataka, India.
Correspondence to: Dr KR Bharath Kumar Reddy, Indira
Gandhi Institute of Child Health, South Health Complex, Dharmaram Post,
Bangalore 560 029, Karnataka, India.
Email:
[email protected]
|
Objectives: To study the role of furosemide infusion in the
management of Acute respiratory distress syndrome (ARDS) associated with
dengue fever.
Methods: Children between the
ages of 1 month to 18 years, who fulfilled the WHO clinical criteria for
dengue infection and American European Consensus Criteria criteria for
ARDS with Dengue IgM positivity, were evaluated. Patients were studied
as group D (receiving diuretic therapy alone) and group B (both
ventilation and diuretics), and compared to a historical control group V
(ventilation alone). Furosemide infusion was administered at 0.05-0.1
mg/kg/hour for 48 hours, maintaining a urine output of 2-4 mL/kg/hour.
Results: There was a significant
difference in survival in the three groups. Significant difference was
noted between pre- and post-intervention arterial blood gases with
respect to PCO2 (P=0.02), pO2 (P=0.003),
PaO2/FaO2 ratio (P<0.001) and
alveolar-arteriolar oxygen gradient (P=0.002).
Conclusion: Diuretic infusion
improves outcome in dengue with ARDS.
Keywords: ARDS, Dengue, Diuretics, Outcome.
|
Dengue hemorrhagic fever (DHF) and Dengue Shock
Syndrome (DSS) constitute important causes of death, with protean
clinical manifestations, in those infected with the dengue virus. The
mortality rate with severe forms of dengue infection may approach 47%
[1]. Only one of three children with associated Acute respiratory
distress syndrome (ARDS) survives [2]. ARDS complicating dengue fever is
reported with an estimated frequency of 2.4% [3,4].
The World Health Organization (WHO) guidelines [5]
offer a useful approach to immediate fluid resuscitation in various
stages of the disease. Kabra, et al. [6] and Soni, et al.
[7] have described difficulties in fluid management in children in the
Indian context. Published data suggest maintaining a negative fluid
balance for improved outcomes in ARDS [8]. Studies have demonstrated
lower extra-vascular lung water, lesser mechanical ventilation and
better survival with fluid restriction in comparison to standard fluid
protocols [9]. Data to support the role of diuretics in pediatric ARDS
are scarce [10]. Recently, Ranjit, et al. [11] described
successful management of complicated dengue infection with judicious
fluid removal. The objective of present study was to evaluate the role
of diuretic infusion in improving respiratory parameters and mortality
in children with dengue fever complicated by ARDS.
Methods
This prospective study was conducted in Indira Gandhi
Institute of Child Health, a tertiary care referral centre with a
25-bedded pediatric intensive care unit (PICU) and 20-bedded dengue
ward. Ethical clearance from the Institution’s ethical committee was
obtained to conduct this study. Participants included children between 1
month to 18 years of age diagnosed with dengue fever as per the WHO
clinical definition. ARDS was defined as per the American European
Consensus Criteria [12]. Evidence of left atrial hypertension was
assessed clinically and by echocardiography. Disease severity of dengue
fever was graded as per the WHO guidelines and by Pediatric Risk of
Mortality (PRISM) III scores.
Patients included between September 2010 and December
2011 were considered group D in whom diuretic therapy was introduced as
a modality of treatment. Those who subsequently required ventilation
were considered group B. Children who were diagnosed with dengue fever
with ARDS prior to the introduction of diuretic therapy (between
December 2009 and August 2010) were considered group V (who were all
ventilated as the only modality of treatment). Furosemide infusion was
used at a dose of 0.05-0.1 mg/kg/hour and was titrated to maintain a
urine output of 2-4 mL/kg/hour. Arterial blood gases before and after 48
hours of starting diuretic therapy were compared.
The chi-squared test was used to compare the
difference between proportions. Students t-test was conducted to
compare means. 95% confidence intervals of data were calculated from
means. The Mann-Whitney U nonparametric test was used to determine
differences between medians of groups. P value of less than 0.05
was taken as significant.
Results
Of the 1525 children admitted with dengue fever, 110
developed ARDS, accounting for an incidence of 7.2%. Group D, V and B
consisted of 46, 42 and 22 children respectively. Three children were
withdrawn from the study and diuretic infusion was stopped in view of
systemic hypotension requiring inotropic support. All 110 children were
dengue IgM positive. The mean (SD) time of onset of ARDS from the first
symptom was 7.5 (2.5) days.
Table I shows the baseline characteristics
and outcome. There was no significant difference in mortality with
respect to age (P=0.09) or gender (P=0.5). The survival
rates were 100%, 7.2% and 9% in group D, V and B, respectively (P
<0.001). There was no statistical difference in the grades of dengue
fever or PRISM III score between survivors and non-survivors in group V
(P = 0.4). In group B, PRISM III score of survivors was 12.5 and
16.5 for non-survivors (P = 0.05). Groups D and V were comparable
by both WHO grading of DHF and mean PRISM III score.
TABLE I Baseline Characteristics of Study Subjects (N=110); No.(%)
Age of study subjects |
Group D (Diuretics only)
|
Group V (Ventilation only) |
Group B (Diuretics with ventilation) |
|
Survivors |
Non-survivors |
Survivors |
Non-survivors |
Survivors |
Non-survivors |
< 1 year |
3 (6.6) |
0 (0) |
1 (33.3) |
3 (7.6) |
1 (50) |
1 (5) |
1 - 5 years |
12 (26) |
0 (0) |
2 (66.7) |
10 (25.6) |
1 (50) |
5 (25) |
5 - 10 years |
16 (34.8) |
0 (0) |
0 (0) |
12 (30.7) |
0 (0) |
6 (30) |
10 -18 years |
15 (32.6) |
0 (0) |
0 (0) |
14 (35.9) |
0 (0) |
8 (40) |
Total (survival rate) |
46 (100) |
0 (0) |
3 (7.2) |
39 (92.8) |
2 (9) |
20 (91) |
Table II compares the arterial blood gases of
children in Group D before and 48 hours after initiating diuretic
therapy. There was a significant difference in pCO2, pO2, PF ratio and
A-a gradient pre- and post-intervention.
TABLE II Pre-intervention and Post-intervention Arterial Blood Gas in Group D (Only Diuretic Therapy)
Values |
Pre-intervention
|
Post-intervention |
P
|
|
Mean (SD) |
Mean (SD) |
value
|
pH |
7.43 (0.07) |
7.40 (0.06) |
0.18 |
PCO2 |
25.92 (8.85) |
31.41 (6.92) |
0.02 |
PO2 |
73.84 (27.2) |
102.43 (38.5) |
0.003 |
PaO2/FiO2
|
167.51(50.3) |
332.29 (153.7) |
<0.001 |
A-a gradient |
182.47 (75.8) |
71.99 (127.9) |
0.002 |
Discussion
The present study demonstrated the efficacy of
furosemide infusion in ARDS with dengue infection. There was also a
significant difference in survival between those children who received
furosemide infusion alone and those who failed diuretic therapy and
required mechanical ventilation. A significant increase in all these
parameters is noted following furosemide infusion, thus demonstrating an
improvement in oxygenation.
Our results are similar to the report by Ranjit,
et al. [11] who demonstrated the efficacy of fluid removal using
diuretics or dialysis in children with dengue fever. The efficacy of
furosemide infusion with respect to changes in the arterial blood gas
demonstrates its role in respiratory function.
Many patients with dengue fever who fulfill the
criteria for ARDS may actually be in a state of fluid overload. It is
known that in the recovery phase of dengue fever, there is reabsorption
of fluid from the extra vascular compartment. In these patients,
diuretics should be tried, which could improve oxygenation and avoid the
need for mechanical ventilation.
This study was limited due to the insufficient data
available regarding the total fluid intake and output of the patients.
Also, in comparing with historical controls, there were associated
confounding factors such as different caregivers and a different support
structure. The potassium and magnesium values were not measured before
and after intervention. A high mortality rate in the ventilated group of
patients could due to late referrals and high incidence of nosocomial
infections. ARDS is an important complication of dengue fever, which
needs to be recognized and treated early. Furosemide infusion could
improve survival in developing countries where access to mechanical
ventilation is limited and its outcome is poor.
Contributors: KRBKR: Study conception, data
analysis and interpretation; GVB: manuscript drafting, Shivananda:
critical analysis and revision of manuscript. All authors approved the
final version.
Funding: none; Competing interests: None
stated.
What This Study Adds?
· Furosemide infusion improves survival
in the management of Dengue fever with ARDS, with significant
improvement in oxygenation.
|
References
1. Agarwal R, Kapoor S, Nagar R. A clinical study of
patients with dengue haemorrhagic fever during the epidemic of 1996 at
Lucknow, India. Southeast Asian J Trop Med Public Health.
1999;30:735-40.
2. Lum LC, Thong MK, Cheah YK. Dengue associated
adult respiratory distress syndrome. Ann Trop Paediatr. 1995;15:335-9.
3. Kamath SR, Ranjit S. Clinical features,
complications and atypical manifestations of children with severe forms
of dengue hemorrhagic fever in South India. Indian J Pediatr.
2006;73:889-95.
4. Dhooria GS, Bhat D, Bains HS. Clinical profile and
outcome in children of dengu hemorrhagic fever in North India. Iran J
Pediatr. 2008;180:222-8.
5. Dengue: Guidelines for Diagnosis, Treatment,
Prevention and Control - New edition. Geneva, WHO, 2009.
6. Kabra SK, Jain Y, Singhal T, Ratageri VH. Dengue
hemorrhagic fever: Clinical manifestations and management. Indian J
Pediatr. 1999;66:93-101.
7. Soni A, Chugh K, Sachdev A, Gupta D. Management of
dengue fever in ICU. Indian J Pediatr. 2001;68:1051-55.
8. Lewis CA, Martin GS. Understanding and managing
fluid balance in patients with acute lung injury. Curr Opin Crit Care.
2004;10:13-7.
9. Martin GS, Eaton S, Mealer M, Moss M.
Extravascular lung water in patients with severe sepsis: a prospective
cohort study. Crit Care. 2005;9:74-82.
10. Martin GS, Mangialardi RJ, Wheeler AP. Albumin
and furosemide therapy in hypoproteinemic patients with acute lung
injury. Crit Care Med. 2002;30:2175-82.
11. Ranjit S, Kissoon N, Jayakumar I. Aggressive
management of dengue shock syndrome may decrease mortality rate: A
suggested protocol. Pediatr Crit Care Med. 2005;4:412-9.
12. Bernard GR, Artigas A, Brigham KL, Carlet J,
Falke K, Hudson L, et al. Report of the American-European
consensus conference on ARDS: definitions, mechanisms, relevant outcomes
and clinical trial coordination. The Consensus Committee. Intensive Care
Med. 1994;20:225-32.
|
|
|
|